In Treatment of Hypertension (high blood pressure) Hypertension or an increase in blood pressure occurs when the blood vessels that supply blood to your heart become narrow. As a result of this, blood cannot flow smoothly to the heart, heart rate increases and it fails to pump blood effectively to other parts of the body. This puts a strain on the heart that can cause a chest pain or even a heart attack. Qsart-B25 Tablet ER reduces pressure in the blood vessels. It relaxes the blood vessels so that blood can flow more easily to your heart. This reduces strain on the heart and slows down heart rate. This further reduces the risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
It is unsafe to consume alcohol with Qsart
Pregnancy : CONSULT YOUR DOCTOR
B25 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life
Breast feeding : SAFE IF PRESCRIBED
B25 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Qsart
Kidney : SAFE IF PRESCRIBED
B25 Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Qsart
Liver : CAUTION
B25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Qsart
If you miss a dose of Qsart-B25 Tablet ER, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Tricorn Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Spansa Pharmaceuticals Pvt. Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pride Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pficus De Med Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Daylon Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elder Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Kaspar Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Europa Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)